Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - FENNEC PHARMACEUTICALS INC.v322956_ex99-1.htm




Washington, D.C. 20549






Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934


Date of report (Date of earliest event reported)  September 4, 2012


Adherex Technologies Inc.

(Exact Name of Registrant as Specified in Its



Canada   001-32295   20-0442384

(State or Other Jurisdiction

of Incorporation)



File Number)


(IRS Employer

Identification No.)


PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, NC 27709

(Address of Principal Executive Offices) (Zip Code)



(Registrant’s Telephone Number, Including Area Code)


Not applicable.

(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 8.01Other Events


On September 4, 2012, Adherex Technologies, Inc. (the “Company”) issued a press release to announce that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at the Waldorf Astoria Hotel, in New York on September 11 at 4:30 pm EST. The full text of the press release is furnished as Exhibit 99.1.




99.1Press Release issued by Adherex Technologies, Inc. dated September 4, 2012.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Dated: September 4, 2012 Adherex Technologies Inc.  
  By: /s/ Robert Andrade  
    Chief Financial Officer